STATISTICAL ANALYSIS OF SAFETY DATA IN LONG-TERM CLINICAL TRIALS

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "STATISTICAL ANALYSIS OF SAFETY DATA IN LONG-TERM CLINICAL TRIALS"

Transcription

1 STATISTICAL ANALYSIS OF SAFETY DATA IN LONG-TERM CLINICAL TRIALS Tailiang Xie, Ping Zhao and Joel Waksman, Wyeth Consumer Healthcare Five Giralda Farms, Madison, NJ 794 KEY WORDS: Safety Data, Adverse Event, Statistical Analysis, Multivariate Survival Analysis, Clinical Trial. 1. Introduction In the past 4 years, approximately 15 drugs worldwide have been withdrawn from market for safety-related reasons since the withdrawal of thalidomide in A recent article claimed that serious adverse events (AEs) are now between the fourth and sixth leading cause of death in the United States. 2 In the ICH-E9, it is clearly stated that in all clinical trials, the evaluation of safety and tolerability of a drug constitutes an important element of the overall benefit/risk assessment. 3 Over the past decades, although much research has been done and many statistical methods have been utilized for analyzing efficacy data, not much has been utilized directly for the analysis of safety data. One of the reasons might be the complicity of safety data, particularly the data from long-term trials. Unlike efficacy analysis, the Type II error is usually of more concern in the safety analysis, especially for serious AEs. Therefore, more powerful statistical methods should be used. To date, most of the analyses of safety data are routine and exploratory in nature. Listing of AEs and summary of the crude rate are among the most commonly used analyses in regulatory submissions and publications. The crude rate is defined as the number of subjects with the event occurring at any time during exposure, divided by the total number of subjects exposed, regardless of duration of exposure, and it is usually analyzed via Fisher s exact test. This crude rate method may be efficient and sufficient for acute drug use in single-dose trials because the duration of drug exposure is usually short and equal among subjects 4. However, for longterm clinical trials with chronic and variable exposures and multiple incidences of AEs, the crude rate method could be invalid and misleading. There are at least three drawbacks associated with the crude rate method for long-term trials. First, because multiple incidences of an AE are counted only once for each subject during the entire trial, the crude rate method could be misleading without reference to chronic exposure of medication and multiple incidences of the same AE. Second, the crude rate method does not take into account important covariates that may have potential impacts on AE, such as demographic and baseline characteristics. Finally, the crude rate method is mostly underpowered for evaluating AE data. The purpose of this paper is to compare and discuss alternative methods for AE analysis. Methods to be discussed are the Cochran- Mantel-Haenszel (CMH) test, Poisson regression and two multivariate survival analysis models, Anderson-Gill multiplicative hazards model (AG model) 5 and proportional mean model (PM model) 6. The relative performance of these procedures in terms of power and Type I error rate will be evaluated using simulation studies. 2. Aspects of Safety Data in Long-term Trials Long-term clinical trials have a number of unique aspects important to AE assessment. Compared to single-dose trials, the drop out rate is usually higher in long-term trials, which results in variable duration of exposure time. Consider a long-term clinical trial illustrated in Figure 1, where there were 1, subjects enrolled in a one-year clinical trial. Most of the subjects remained exposed during the first three months. Approximately half of the subjects dropped out after six months and only a quarter of the subjects remained active at the end of the trial. 3824

2 Figure 1. Exposure Pattern for Subjects Followed-up Month of Exposure A third aspect of AE data in long-term trials is that a subject may experience multiple incidences of the same AE. Consider a 1-day clinical trial, in which there were a total of 85 incidences of an AE reported by 98 subjects. A useful graphical method to show multiple AE incidences within subjects is depicted in Figure 3, where each horizontal line represents the time course of a subject who was in the trial and the dots on the line represent the onset of AE incidences for the subject. Figure 3. Example Data with Multiple Incidences of AE Number of Events A second aspect is that the time pattern of an AE might be different for different drugs. Figure 2 illustrates an example in which the AE rate was approximately the same among three treatment groups. For Drug A, most of the AE incidences occurred at the beginning of the treatment and the number of AEs gradually declined until Month 6 and eventually disappeared. This may indicate a gradual buildup of tolerance to Drug A. For Drug B, most of the AE incidences were distributed evenly during Months 1-6. For Drug C, there was no AE incidence until Month 3. The AE rate then peaked around Months 6-8. This may indicate a cumulative toxicity of Drug C. Although the crude rates were the same for all three drugs, the time course when the AE occurred was completely different. 5 Figure 2. Pattern of AEs for Three Drugs Month of Exposure Drug A Drug B Drug C Subjects Study Days Finally, a fourth aspect of long-term AE data is the dependence among AEs within a subject, in the sense that a subject who had an AE is likely to have the same AE again. For instance, multiple incidences of somnolence can be induced by certain antihistamine drugs. These aspects undoubtedly bring challenges in assessing safety and tolerability of a drug for long-term use. Clearly, the conventional crude rate method is subject to bias in analysis of longterm safety data because it throws out a great deal of information. Methods capable of capturing these aspects should be used. In the next section, the crude rate method, CMH test, Poisson regression, AG model and PM model will be compared. 3. Comparison of Statistical Methods Among the methods compared, the AG model 5 6 and PM model are relatively recent advancements of multivariate survival analysis, and will be summarized briefly. 3825

3 Let N(t) be a counting process representing number of events occurring over the time interval [, t] (t ). Assuming that N(t) is a nonhomogeneous Poisson process and letting Λ Z (t) be the cumulative intensity function of N(t), conditional on a p-dimensional covariate process Z, then the AG model takes the form of β T Z ( t) Λ ( t) = e Λ ( t), Z where Λ is an unspecified continuous intensity function and β is a p-vector of regression parameters. By contrast, the PM model does not impose the Poisson assumption on N(t) and takes the form of β T Z ( t ) m ( t) = e m ( t), Z where m z (t)=e{ N(t) Z }, a mean function of N(t). If N(t) is a non-homogeneous Poisson process, then the mean function is the cumulative intensity function. Therefore, the PM model is an extension of the AG model. By assuming a non-homogeneous Poisson structure of N(.), the AG model essentially assumes independence among events. The naïve variance-covariance estimator (i.e. the Fisher information matrix) is used. However, the PM model allows dependence among events. The robust variance-covariance estimator (i.e. the sandwich estimator) is used. The crude rate method and CMH test are nonparametric; while the Poisson regression and AG model are parametric, in that they assume the number of events follows a Poisson distribution. The PM model is a semi-parametric method, in that it does not assume a specific distribution of N(t), however, it does assume a proportional structure of the mean functions between treatment groups. Among the compared methods, the PM model is the only method that is capable of capturing all of the mentioned aspects of safety data in long-term trials. A comparison of the methods is summarized in Table 1. Table 1. Comparison of Statistical Methods Aspect Consideration Method PA MT TE DP CE DE Crude No No No No No No CMH No Yes No No No No Poisson Yes Yes No No Yes No AG Yes Yes Yes No Yes Yes PM Yes* Yes Yes Yes Yes Yes *PM model is only semi-parametric. PA: Parametric assumption. MT: Multiplicity. TE: Time to event. DP: Dependence. CE: Covariate effect. DE: Duration of Exposure. 4. Simulation Results A number of simulation studies were conducted to assess the performance of these methods. We focused on the following aspects of performance: power, Type I error and robustness. The number of events was first simulated via a Poisson distribution for power and Type I error assessment. To assess robustness, the number of events was then simulated via a contaminated Poisson distribution. All simulations were performed using SAS Version 6.12 (SAS Institute, Cary, NC). For Poisson regression, the SAS GENMOD procedure was used. For both the AG and PM models, the SAS PHREG procedure was used with counting process data input. For the PM model, the SAS IML procedure also was used to compute the robust covariance-variance estimator. Data with Poisson Distribution In order to assess power, the AE data sets were generated, in which the number of AEs followed Poisson distributions with rates of 1 and 1.5, and the time to AE had marginal exponential distributions with medians of 1 and 1.5 days for the reference and test treatment groups, respectively. The correlation coefficients ρ among times to AE were.,.4,.6 and.9. There were 1 subjects in each treatment group. For the Type I error assessment, the AE data sets were generated in the same manner, except that the number of AEs followed Poisson distributions with rates of 1, and the time to AE had marginal exponential distributions with medians of 1 day for both of the reference and test treatment groups. 3826

4 The simulated data were then analyzed using each of the five methods. The simulation was repeated 1, times for each combination of correlation and method, and the proportion of times the null hypothesis of equal treatment AE rates was rejected at the.5 level was recorded. Table 2 has the results. Table 2. Comparison of the Simulated Power and Type I Error ρ Method Power Type I Error. Crude CMH Poisson AG PM Crude CMH Poisson AG PM Crude CMH Poisson AG PM Crude CMH Poisson AG PM Unsurprisingly, the crude rate method had the lowest power among all methods compared. All other methods had reasonably high power, especially the AG model, which took advantage of meeting all its model assumptions and utilizing almost all the information in the data. The PM model was the second most powerful method among all methods compared. For those methods that do not take into account the dependence of AEs within subject, the power was stable. For the PM model, however, as expected the power decreased as the withinsubject correlation increased. As shown in Table 2, all methods had reasonable Type I error rate, except for the AG model that had a Type I error rate in a range of To further investigate why the AG model inflates the Type I error, we performed additional simulations as shown in Table 3. Table3.TypeIerrorforAGmodel ρ N=2 N=3 N=ranpoi() N: the number of events per subject. N=ranpoi() means the number of events following a Poisson distribution. For the cases with fixed number of events, the Type I error inflation may be due to the increasing of within-subject correlation in the simulated data. For the case with random number of events, the inflation may be due to not only the increasing of within-subject correlation in the simulated data, but also the violation of the proportionality property caused by the randomness of the number of events. Non-Poisson Distribution Data In this simulation study, we attempted to assess the robustness of these methods under the non- Poisson situation, especially for the Poisson regression and the AG model. The AE data sets were generated in a similar manner as above, in which the time to AEs was simulated with the same distribution. The number of AEs, however, was contaminated by a random noise added to the Poisson distribution in order to create overdispersion to the data. The simulation was run for 1, times for each combination of correlation and method. Because the results were consistent across different correlation coefficients, only the results for correlation of.6 are displayed. Table 4. Comparison of Power for Non- Poisson Data (ρ =.6) Method Simulated Power Poisson Regression.28 AG.898 PM

5 As shown in Table 4, the powers for the Poisson regression and AG model were decreased. A severe impact was observed on the Poisson regression. For the AG model, although the Poisson condition was not held, the difference between the median times to event helped to lessen the power loss. Since the PM model is distribution free, its power remained essentially unchanged. 5. Discussion and Conclusion Since failure in detecting elevated AE rates related to a study drug could result in severe consequences, the Type II error is usually of more concern than the Type I error especially for serious AEs, in the safety analysis. The usual crude rate method is severely under-powered for long-term clinical trials. Thus it should not be used routinely for confirmatory analysis, especially for analyzing serious AEs. In addition, the crude rate method cannot factor in the effects of covariates that may affect AEs. The CMH test and Poisson regression are relatively powerful. However, neither of the methods can take into account the time course of AEs and the dependence of recurrent AEs within subjects. In addition, the Poisson regression can be severely impacted by violation of its parametric assumption. fairly easy to implement it in major software, such as SAS (PHREG and IML) and S-Plus (COXPH). Thus, the PM model has the best overall performances in terms of power, Type I error rate, robustness and capacity of capturing all aspects of safety data in long-term clinical trials. References 1. Spriet-Pourra C, Auriche M. (1994). Drug withdrawal from sale. 2 nd edition. Scrip Reports. Richmond, England: PJB Publications Ltd. 2. Lazarou J, Pomeranz BH, Corey PN. (1998). Incidence of adverse drug reactions in hospitalized patients. JAMA; 279: ICH-E9. 4. O Neil RT. (1987). Statistical analysis of adverse event data from clinical trials. Special emphasis on serious events. Drug Inf. J.; 21: Anderson, P.K. and Gill, R.D. (1982). Cox s Regression Model for counting processes: a large sample study. The Annals of Statistics, 1, Lin, D.Y., Wei, L. J., Yang, I. And Ying, Z. (2). Semiparametric regression for the mean and rate functions of recurrent events. J. R. Statist. Soc. B; 62, Part 4, pp The AG model has the highest power when all conditions pertaining to its model assumption are met. However, it does not take the dependence into account. As indicated by the Table 3, it should be used with caution when the number of events was widely divergent or the time to events were clustered type data. The PM model has reasonable Type I error rate, while its power is only slightly lower than that of the AG model. It is capable of capturing all aspects of long-term safety data. In addition, it is built under a regression framework and thus able to take into account the effects of covariates such as baseline and demographic characteristics. Unlike the AG model and Poisson regression, it is robust to the violation of the underlying distribution assumption. Additionally, because it models the mean instead of intensity function as in the AG model, it is intuitive and easily interpreted. Finally, it is 3828

Survival Analysis Using SPSS. By Hui Bian Office for Faculty Excellence

Survival Analysis Using SPSS. By Hui Bian Office for Faculty Excellence Survival Analysis Using SPSS By Hui Bian Office for Faculty Excellence Survival analysis What is survival analysis Event history analysis Time series analysis When use survival analysis Research interest

More information

SAS and R calculations for cause specific hazard ratios in a competing risks analysis with time dependent covariates

SAS and R calculations for cause specific hazard ratios in a competing risks analysis with time dependent covariates SAS and R calculations for cause specific hazard ratios in a competing risks analysis with time dependent covariates Martin Wolkewitz, Ralf Peter Vonberg, Hajo Grundmann, Jan Beyersmann, Petra Gastmeier,

More information

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD Tips for surviving the analysis of survival data Philip Twumasi-Ankrah, PhD Big picture In medical research and many other areas of research, we often confront continuous, ordinal or dichotomous outcomes

More information

Chapter 1 Introduction. 1.1 Introduction

Chapter 1 Introduction. 1.1 Introduction Chapter 1 Introduction 1.1 Introduction 1 1.2 What Is a Monte Carlo Study? 2 1.2.1 Simulating the Rolling of Two Dice 2 1.3 Why Is Monte Carlo Simulation Often Necessary? 4 1.4 What Are Some Typical Situations

More information

How to choose a statistical test. Francisco J. Candido dos Reis DGO-FMRP University of São Paulo

How to choose a statistical test. Francisco J. Candido dos Reis DGO-FMRP University of São Paulo How to choose a statistical test Francisco J. Candido dos Reis DGO-FMRP University of São Paulo Choosing the right test One of the most common queries in stats support is Which analysis should I use There

More information

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background: 1.0 Abstract Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA Keywords Rationale and Background: This abbreviated clinical study report is based on a clinical surveillance

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

Introduction. Survival Analysis. Censoring. Plan of Talk

Introduction. Survival Analysis. Censoring. Plan of Talk Survival Analysis Mark Lunt Arthritis Research UK Centre for Excellence in Epidemiology University of Manchester 01/12/2015 Survival Analysis is concerned with the length of time before an event occurs.

More information

Introduction to Event History Analysis DUSTIN BROWN POPULATION RESEARCH CENTER

Introduction to Event History Analysis DUSTIN BROWN POPULATION RESEARCH CENTER Introduction to Event History Analysis DUSTIN BROWN POPULATION RESEARCH CENTER Objectives Introduce event history analysis Describe some common survival (hazard) distributions Introduce some useful Stata

More information

DEVELOPING AN ANALYTICAL PLAN

DEVELOPING AN ANALYTICAL PLAN The Fundamentals of International Clinical Research Workshop February 2004 DEVELOPING AN ANALYTICAL PLAN Mario Chen, PhD. Family Health International 1 The Analysis Plan for a Study Summary Analysis Plan:

More information

Introduction to survival analysis

Introduction to survival analysis Chapter Introduction to survival analysis. Introduction In this chapter we examine another method used in the analysis of intervention trials, cohort studies and data routinely collected by hospital and

More information

Sample Size and Power in Clinical Trials

Sample Size and Power in Clinical Trials Sample Size and Power in Clinical Trials Version 1.0 May 011 1. Power of a Test. Factors affecting Power 3. Required Sample Size RELATED ISSUES 1. Effect Size. Test Statistics 3. Variation 4. Significance

More information

When Does it Make Sense to Perform a Meta-Analysis?

When Does it Make Sense to Perform a Meta-Analysis? CHAPTER 40 When Does it Make Sense to Perform a Meta-Analysis? Introduction Are the studies similar enough to combine? Can I combine studies with different designs? How many studies are enough to carry

More information

Age to Age Factor Selection under Changing Development Chris G. Gross, ACAS, MAAA

Age to Age Factor Selection under Changing Development Chris G. Gross, ACAS, MAAA Age to Age Factor Selection under Changing Development Chris G. Gross, ACAS, MAAA Introduction A common question faced by many actuaries when selecting loss development factors is whether to base the selected

More information

Checklists and Examples for Registering Statistical Analyses

Checklists and Examples for Registering Statistical Analyses Checklists and Examples for Registering Statistical Analyses For well-designed confirmatory research, all analysis decisions that could affect the confirmatory results should be planned and registered

More information

MISSING DATA TECHNIQUES WITH SAS. IDRE Statistical Consulting Group

MISSING DATA TECHNIQUES WITH SAS. IDRE Statistical Consulting Group MISSING DATA TECHNIQUES WITH SAS IDRE Statistical Consulting Group ROAD MAP FOR TODAY To discuss: 1. Commonly used techniques for handling missing data, focusing on multiple imputation 2. Issues that could

More information

SUMAN DUVVURU STAT 567 PROJECT REPORT

SUMAN DUVVURU STAT 567 PROJECT REPORT SUMAN DUVVURU STAT 567 PROJECT REPORT SURVIVAL ANALYSIS OF HEROIN ADDICTS Background and introduction: Current illicit drug use among teens is continuing to increase in many countries around the world.

More information

UNDERSTANDING CLINICAL TRIAL STATISTICS. Prepared by Urania Dafni, Xanthi Pedeli, Zoi Tsourti

UNDERSTANDING CLINICAL TRIAL STATISTICS. Prepared by Urania Dafni, Xanthi Pedeli, Zoi Tsourti UNDERSTANDING CLINICAL TRIAL STATISTICS Prepared by Urania Dafni, Xanthi Pedeli, Zoi Tsourti DISCLOSURES Urania Dafni has reported no conflict of interest Xanthi Pedeli has reported no conflict of interest

More information

Fairfield Public Schools

Fairfield Public Schools Mathematics Fairfield Public Schools AP Statistics AP Statistics BOE Approved 04/08/2014 1 AP STATISTICS Critical Areas of Focus AP Statistics is a rigorous course that offers advanced students an opportunity

More information

Introduction to Fixed Effects Methods

Introduction to Fixed Effects Methods Introduction to Fixed Effects Methods 1 1.1 The Promise of Fixed Effects for Nonexperimental Research... 1 1.2 The Paired-Comparisons t-test as a Fixed Effects Method... 2 1.3 Costs and Benefits of Fixed

More information

How to interpret scientific & statistical graphs

How to interpret scientific & statistical graphs How to interpret scientific & statistical graphs Theresa A Scott, MS Department of Biostatistics theresa.scott@vanderbilt.edu http://biostat.mc.vanderbilt.edu/theresascott 1 A brief introduction Graphics:

More information

Antipsychotic drugs are the cornerstone of treatment

Antipsychotic drugs are the cornerstone of treatment Article Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic T. Scott Stroup, M.D.,

More information

PROPERTIES OF THE SAMPLE CORRELATION OF THE BIVARIATE LOGNORMAL DISTRIBUTION

PROPERTIES OF THE SAMPLE CORRELATION OF THE BIVARIATE LOGNORMAL DISTRIBUTION PROPERTIES OF THE SAMPLE CORRELATION OF THE BIVARIATE LOGNORMAL DISTRIBUTION Chin-Diew Lai, Department of Statistics, Massey University, New Zealand John C W Rayner, School of Mathematics and Applied Statistics,

More information

Statistics and research

Statistics and research Statistics and research Usaneya Perngparn Chitlada Areesantichai Drug Dependence Research Center (WHOCC for Research and Training in Drug Dependence) College of Public Health Sciences Chulolongkorn University,

More information

Cancer Survival Analysis

Cancer Survival Analysis Cancer Survival Analysis 2 Analysis of cancer survival data and related outcomes is necessary to assess cancer treatment programs and to monitor the progress of regional and national cancer control programs.

More information

Statistics Graduate Courses

Statistics Graduate Courses Statistics Graduate Courses STAT 7002--Topics in Statistics-Biological/Physical/Mathematics (cr.arr.).organized study of selected topics. Subjects and earnable credit may vary from semester to semester.

More information

Introduction. Ethical Issues in the Statistical Analysis of Clinical Research Data. Introduction. Introduction. Statistical Quality or Ethical Degree

Introduction. Ethical Issues in the Statistical Analysis of Clinical Research Data. Introduction. Introduction. Statistical Quality or Ethical Degree Ethical Issues in the Statistical Analysis of Clinical Research Data Roger J. Lewis, MD, PhD Department of Emergency Medicine Harbor-UCLA Medical Center Torrance, California Introduction Types of data-centered

More information

TUTORIAL on ICH E9 and Other Statistical Regulatory Guidance. Session 1: ICH E9 and E10. PSI Conference, May 2011

TUTORIAL on ICH E9 and Other Statistical Regulatory Guidance. Session 1: ICH E9 and E10. PSI Conference, May 2011 TUTORIAL on ICH E9 and Other Statistical Regulatory Guidance Session 1: PSI Conference, May 2011 Kerry Gordon, Quintiles 1 E9, and how to locate it 2 ICH E9 Statistical Principles for Clinical Trials (Issued

More information

Checking proportionality for Cox s regression model

Checking proportionality for Cox s regression model Checking proportionality for Cox s regression model by Hui Hong Zhang Thesis for the degree of Master of Science (Master i Modellering og dataanalyse) Department of Mathematics Faculty of Mathematics and

More information

Basic research methods. Basic research methods. Question: BRM.2. Question: BRM.1

Basic research methods. Basic research methods. Question: BRM.2. Question: BRM.1 BRM.1 The proportion of individuals with a particular disease who die from that condition is called... BRM.2 This study design examines factors that may contribute to a condition by comparing subjects

More information

MISSING DATA: THE POINT OF VIEW OF ETHICAL COMMITTEES

MISSING DATA: THE POINT OF VIEW OF ETHICAL COMMITTEES I CONGRESSO NAZIONALE BIAS 2009 29/30 APRILE 2009 ELI LILLY SESTO FIORENTINO (FI) MISSING DATA: THE POINT OF VIEW OF ETHICAL COMMITTEES Anna Chiara Frigo Department of Environmental Medicine and Public

More information

Module 9: Nonparametric Tests. The Applied Research Center

Module 9: Nonparametric Tests. The Applied Research Center Module 9: Nonparametric Tests The Applied Research Center Module 9 Overview } Nonparametric Tests } Parametric vs. Nonparametric Tests } Restrictions of Nonparametric Tests } One-Sample Chi-Square Test

More information

Minitab Guide. This packet contains: A Friendly Guide to Minitab. Minitab Step-By-Step

Minitab Guide. This packet contains: A Friendly Guide to Minitab. Minitab Step-By-Step Minitab Guide This packet contains: A Friendly Guide to Minitab An introduction to Minitab; including basic Minitab functions, how to create sets of data, and how to create and edit graphs of different

More information

INTERPRETING THE REPEATED-MEASURES ANOVA

INTERPRETING THE REPEATED-MEASURES ANOVA INTERPRETING THE REPEATED-MEASURES ANOVA USING THE SPSS GENERAL LINEAR MODEL PROGRAM RM ANOVA In this scenario (based on a RM ANOVA example from Leech, Barrett, and Morgan, 2005) each of 12 participants

More information

Tests for Two Survival Curves Using Cox s Proportional Hazards Model

Tests for Two Survival Curves Using Cox s Proportional Hazards Model Chapter 730 Tests for Two Survival Curves Using Cox s Proportional Hazards Model Introduction A clinical trial is often employed to test the equality of survival distributions of two treatment groups.

More information

Applied Statistics. J. Blanchet and J. Wadsworth. Institute of Mathematics, Analysis, and Applications EPF Lausanne

Applied Statistics. J. Blanchet and J. Wadsworth. Institute of Mathematics, Analysis, and Applications EPF Lausanne Applied Statistics J. Blanchet and J. Wadsworth Institute of Mathematics, Analysis, and Applications EPF Lausanne An MSc Course for Applied Mathematicians, Fall 2012 Outline 1 Model Comparison 2 Model

More information

Study Design and Statistical Analysis

Study Design and Statistical Analysis Study Design and Statistical Analysis Anny H Xiang, PhD Department of Preventive Medicine University of Southern California Outline Designing Clinical Research Studies Statistical Data Analysis Designing

More information

Non Parametric Inference

Non Parametric Inference Maura Department of Economics and Finance Università Tor Vergata Outline 1 2 3 Inverse distribution function Theorem: Let U be a uniform random variable on (0, 1). Let X be a continuous random variable

More information

A Mixed Model Approach for Intent-to-Treat Analysis in Longitudinal Clinical Trials with Missing Values

A Mixed Model Approach for Intent-to-Treat Analysis in Longitudinal Clinical Trials with Missing Values Methods Report A Mixed Model Approach for Intent-to-Treat Analysis in Longitudinal Clinical Trials with Missing Values Hrishikesh Chakraborty and Hong Gu March 9 RTI Press About the Author Hrishikesh Chakraborty,

More information

Primary Prevention of Cardiovascular Disease with a Mediterranean diet

Primary Prevention of Cardiovascular Disease with a Mediterranean diet Primary Prevention of Cardiovascular Disease with a Mediterranean diet Alejandro Vicente Carrillo, Brynja Ingadottir, Anne Fältström, Evelyn Lundin, Micaela Tjäderborn GROUP 2 Background The traditional

More information

SUGI 29 Statistics and Data Analysis

SUGI 29 Statistics and Data Analysis Paper 195-29 "Proc Power in SAS 9.1" Debbie Bauer, MS, Sanofi-Synthelabo, Russell Lavery, Contractor, About Consulting, Chadds Ford, PA ABSTRACT Features were added to SAS V9.1 STAT that will allow many

More information

COMPARING DATA ANALYSIS TECHNIQUES FOR EVALUATION DESIGNS WITH NON -NORMAL POFULP_TIOKS Elaine S. Jeffers, University of Maryland, Eastern Shore*

COMPARING DATA ANALYSIS TECHNIQUES FOR EVALUATION DESIGNS WITH NON -NORMAL POFULP_TIOKS Elaine S. Jeffers, University of Maryland, Eastern Shore* COMPARING DATA ANALYSIS TECHNIQUES FOR EVALUATION DESIGNS WITH NON -NORMAL POFULP_TIOKS Elaine S. Jeffers, University of Maryland, Eastern Shore* The data collection phases for evaluation designs may involve

More information

Study Design. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D. Ellis Unger, M.D. Ghanshyam Gupta, Ph.D. Chief, Therapeutics Evaluation Branch

Study Design. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D. Ellis Unger, M.D. Ghanshyam Gupta, Ph.D. Chief, Therapeutics Evaluation Branch BLA: STN 103471 Betaseron (Interferon β-1b) for the treatment of secondary progressive multiple sclerosis. Submission dated June 29, 1998. Chiron Corp. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D.

More information

Design and Analysis of Phase III Clinical Trials

Design and Analysis of Phase III Clinical Trials Cancer Biostatistics Center, Biostatistics Shared Resource, Vanderbilt University School of Medicine June 19, 2008 Outline 1 Phases of Clinical Trials 2 3 4 5 6 Phase I Trials: Safety, Dosage Range, and

More information

Service courses for graduate students in degree programs other than the MS or PhD programs in Biostatistics.

Service courses for graduate students in degree programs other than the MS or PhD programs in Biostatistics. Course Catalog In order to be assured that all prerequisites are met, students must acquire a permission number from the education coordinator prior to enrolling in any Biostatistics course. Courses are

More information

Research Methods & Experimental Design

Research Methods & Experimental Design Research Methods & Experimental Design 16.422 Human Supervisory Control April 2004 Research Methods Qualitative vs. quantitative Understanding the relationship between objectives (research question) and

More information

Brief Communications. Awad Mohamed Ahmed, MD. Abstract

Brief Communications. Awad Mohamed Ahmed, MD. Abstract Awad Mohamed Ahmed, MD Professor of Medicine, University of Bahr Elghazal, Khartoum, Sudan For correspondence Professor Awad Mohamed Ahmed E-mail: awad.sd@gmail.com Tel.: +249 912344936 Abstract Randomized

More information

Association Between Variables

Association Between Variables Contents 11 Association Between Variables 767 11.1 Introduction............................ 767 11.1.1 Measure of Association................. 768 11.1.2 Chapter Summary.................... 769 11.2 Chi

More information

Descriptive Statistics

Descriptive Statistics Descriptive Statistics Primer Descriptive statistics Central tendency Variation Relative position Relationships Calculating descriptive statistics Descriptive Statistics Purpose to describe or summarize

More information

Come scegliere un test statistico

Come scegliere un test statistico Come scegliere un test statistico Estratto dal Capitolo 37 of Intuitive Biostatistics (ISBN 0-19-508607-4) by Harvey Motulsky. Copyright 1995 by Oxfd University Press Inc. (disponibile in Iinternet) Table

More information

Tests of relationships between variables Chi-square Test Binomial Test Run Test for Randomness One-Sample Kolmogorov-Smirnov Test.

Tests of relationships between variables Chi-square Test Binomial Test Run Test for Randomness One-Sample Kolmogorov-Smirnov Test. N. Uttam Singh, Aniruddha Roy & A. K. Tripathi ICAR Research Complex for NEH Region, Umiam, Meghalaya uttamba@gmail.com, aniruddhaubkv@gmail.com, aktripathi2020@yahoo.co.in Non Parametric Tests: Hands

More information

200609 - ATV - Lifetime Data Analysis

200609 - ATV - Lifetime Data Analysis Coordinating unit: Teaching unit: Academic year: Degree: ECTS credits: 2015 200 - FME - School of Mathematics and Statistics 715 - EIO - Department of Statistics and Operations Research 1004 - UB - (ENG)Universitat

More information

When to Use Which Statistical Test

When to Use Which Statistical Test When to Use Which Statistical Test Rachel Lovell, Ph.D., Senior Research Associate Begun Center for Violence Prevention Research and Education Jack, Joseph, and Morton Mandel School of Applied Social Sciences

More information

Sample Size Planning, Calculation, and Justification

Sample Size Planning, Calculation, and Justification Sample Size Planning, Calculation, and Justification Theresa A Scott, MS Vanderbilt University Department of Biostatistics theresa.scott@vanderbilt.edu http://biostat.mc.vanderbilt.edu/theresascott Theresa

More information

STATISTICAL MODELING OF LONGITUDINAL SURVEY DATA WITH BINARY OUTCOMES

STATISTICAL MODELING OF LONGITUDINAL SURVEY DATA WITH BINARY OUTCOMES STATISTICAL MODELING OF LONGITUDINAL SURVEY DATA WITH BINARY OUTCOMES A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the Requirements for the Degree of Doctor

More information

Guideline on missing data in confirmatory clinical trials

Guideline on missing data in confirmatory clinical trials 2 July 2010 EMA/CPMP/EWP/1776/99 Rev. 1 Committee for Medicinal Products for Human Use (CHMP) Guideline on missing data in confirmatory clinical trials Discussion in the Efficacy Working Party June 1999/

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. Current Step 4 version

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. Current Step 4 version INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE THE EXTENT OF POPULATION EXPOSURE TO ASSESS CLINICAL

More information

7.1 The Hazard and Survival Functions

7.1 The Hazard and Survival Functions Chapter 7 Survival Models Our final chapter concerns models for the analysis of data which have three main characteristics: (1) the dependent variable or response is the waiting time until the occurrence

More information

Can I have FAITH in this Review?

Can I have FAITH in this Review? Can I have FAITH in this Review? Find Appraise Include Total Heterogeneity Paul Glasziou Centre for Research in Evidence Based Practice Bond University What do you do? For an acutely ill patient, you do

More information

Nonparametric Statistics

Nonparametric Statistics Nonparametric Statistics J. Lozano University of Goettingen Department of Genetic Epidemiology Interdisciplinary PhD Program in Applied Statistics & Empirical Methods Graduate Seminar in Applied Statistics

More information

T-test & factor analysis

T-test & factor analysis Parametric tests T-test & factor analysis Better than non parametric tests Stringent assumptions More strings attached Assumes population distribution of sample is normal Major problem Alternatives Continue

More information

ECON 142 SKETCH OF SOLUTIONS FOR APPLIED EXERCISE #2

ECON 142 SKETCH OF SOLUTIONS FOR APPLIED EXERCISE #2 University of California, Berkeley Prof. Ken Chay Department of Economics Fall Semester, 005 ECON 14 SKETCH OF SOLUTIONS FOR APPLIED EXERCISE # Question 1: a. Below are the scatter plots of hourly wages

More information

Sample Size Estimation and Power Analysis

Sample Size Estimation and Power Analysis yumi Shintani, Ph.D., M.P.H. Sample Size Estimation and Power nalysis March 2008 yumi Shintani, PhD, MPH Department of Biostatistics Vanderbilt University 1 researcher conducted a study comparing the effect

More information

Clinical Study Synopsis for Public Disclosure

Clinical Study Synopsis for Public Disclosure abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis - which is part of the clinical

More information

Applications of Structural Equation Modeling in Social Sciences Research

Applications of Structural Equation Modeling in Social Sciences Research American International Journal of Contemporary Research Vol. 4 No. 1; January 2014 Applications of Structural Equation Modeling in Social Sciences Research Jackson de Carvalho, PhD Assistant Professor

More information

Probability Calculator

Probability Calculator Chapter 95 Introduction Most statisticians have a set of probability tables that they refer to in doing their statistical wor. This procedure provides you with a set of electronic statistical tables that

More information

Measures of Underlying Inflation

Measures of Underlying Inflation Measures of Underlying Inflation Tony Richards and Tom Rosewall* Various measures of underlying inflation are used at the Reserve Bank. These measures are useful in assessing current inflation pressures

More information

Measuring reliability and agreement

Measuring reliability and agreement Measuring reliability and agreement Madhukar Pai, MD, PhD Assistant Professor of Epidemiology, McGill University Montreal, Canada Professor Extraordinary, Stellenbosch University, S Africa Email: madhukar.pai@mcgill.ca

More information

Modelling spousal mortality dependence: evidence of heterogeneities and implications

Modelling spousal mortality dependence: evidence of heterogeneities and implications 1/23 Modelling spousal mortality dependence: evidence of heterogeneities and implications Yang Lu Scor and Aix-Marseille School of Economics Lyon, September 2015 2/23 INTRODUCTION 3/23 Motivation It has

More information

Hypothesis testing S2

Hypothesis testing S2 Basic medical statistics for clinical and experimental research Hypothesis testing S2 Katarzyna Jóźwiak k.jozwiak@nki.nl 2nd November 2015 1/43 Introduction Point estimation: use a sample statistic to

More information

Business Statistics. Successful completion of Introductory and/or Intermediate Algebra courses is recommended before taking Business Statistics.

Business Statistics. Successful completion of Introductory and/or Intermediate Algebra courses is recommended before taking Business Statistics. Business Course Text Bowerman, Bruce L., Richard T. O'Connell, J. B. Orris, and Dawn C. Porter. Essentials of Business, 2nd edition, McGraw-Hill/Irwin, 2008, ISBN: 978-0-07-331988-9. Required Computing

More information

WHAT IS A JOURNAL CLUB?

WHAT IS A JOURNAL CLUB? WHAT IS A JOURNAL CLUB? With its September 2002 issue, the American Journal of Critical Care debuts a new feature, the AJCC Journal Club. Each issue of the journal will now feature an AJCC Journal Club

More information

Modeling Customer Lifetime Value Using Survival Analysis An Application in the Telecommunications Industry

Modeling Customer Lifetime Value Using Survival Analysis An Application in the Telecommunications Industry Paper 12028 Modeling Customer Lifetime Value Using Survival Analysis An Application in the Telecommunications Industry Junxiang Lu, Ph.D. Overland Park, Kansas ABSTRACT Increasingly, companies are viewing

More information

Methods for Meta-analysis in Medical Research

Methods for Meta-analysis in Medical Research Methods for Meta-analysis in Medical Research Alex J. Sutton University of Leicester, UK Keith R. Abrams University of Leicester, UK David R. Jones University of Leicester, UK Trevor A. Sheldon University

More information

Extending Hypothesis Testing. p-values & confidence intervals

Extending Hypothesis Testing. p-values & confidence intervals Extending Hypothesis Testing p-values & confidence intervals So far: how to state a question in the form of two hypotheses (null and alternative), how to assess the data, how to answer the question by

More information

Chi-square test Fisher s Exact test

Chi-square test Fisher s Exact test Lesson 1 Chi-square test Fisher s Exact test McNemar s Test Lesson 1 Overview Lesson 11 covered two inference methods for categorical data from groups Confidence Intervals for the difference of two proportions

More information

Comparison/Control Groups. Mary Foulkes, PhD Johns Hopkins University

Comparison/Control Groups. Mary Foulkes, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Clinical Studies Section of Labeling for Human Prescription Drug and Biological Products Content and Format U.S. Department of Health and Human Services Food and Drug Administration

More information

BIOSTATISTICS QUIZ ANSWERS

BIOSTATISTICS QUIZ ANSWERS BIOSTATISTICS QUIZ ANSWERS 1. When you read scientific literature, do you know whether the statistical tests that were used were appropriate and why they were used? a. Always b. Mostly c. Rarely d. Never

More information

Placement Stability and Number of Children in a Foster Home. Mark F. Testa. Martin Nieto. Tamara L. Fuller

Placement Stability and Number of Children in a Foster Home. Mark F. Testa. Martin Nieto. Tamara L. Fuller Placement Stability and Number of Children in a Foster Home Mark F. Testa Martin Nieto Tamara L. Fuller Children and Family Research Center School of Social Work University of Illinois at Urbana-Champaign

More information

Multivariate Analysis of Variance (MANOVA): I. Theory

Multivariate Analysis of Variance (MANOVA): I. Theory Gregory Carey, 1998 MANOVA: I - 1 Multivariate Analysis of Variance (MANOVA): I. Theory Introduction The purpose of a t test is to assess the likelihood that the means for two groups are sampled from the

More information

SAMPLE SIZE TABLES FOR LOGISTIC REGRESSION

SAMPLE SIZE TABLES FOR LOGISTIC REGRESSION STATISTICS IN MEDICINE, VOL. 8, 795-802 (1989) SAMPLE SIZE TABLES FOR LOGISTIC REGRESSION F. Y. HSIEH* Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, N Y 10461,

More information

Spatial Statistics Chapter 3 Basics of areal data and areal data modeling

Spatial Statistics Chapter 3 Basics of areal data and areal data modeling Spatial Statistics Chapter 3 Basics of areal data and areal data modeling Recall areal data also known as lattice data are data Y (s), s D where D is a discrete index set. This usually corresponds to data

More information

Semester 2 Statistics Short courses

Semester 2 Statistics Short courses Semester 2 Statistics Short courses Course: STAA0001 - Basic Statistics Blackboard Site: STAA0001 Dates: Sat 10 th Sept and 22 Oct 2016 (9 am 5 pm) Room EN409 Assumed Knowledge: None Day 1: Exploratory

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

SENSITIVITY ANALYSIS AND INFERENCE. Lecture 12

SENSITIVITY ANALYSIS AND INFERENCE. Lecture 12 This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

STATISTICA Formula Guide: Logistic Regression. Table of Contents

STATISTICA Formula Guide: Logistic Regression. Table of Contents : Table of Contents... 1 Overview of Model... 1 Dispersion... 2 Parameterization... 3 Sigma-Restricted Model... 3 Overparameterized Model... 4 Reference Coding... 4 Model Summary (Summary Tab)... 5 Summary

More information

Additional sources Compilation of sources: http://lrs.ed.uiuc.edu/tseportal/datacollectionmethodologies/jin-tselink/tselink.htm

Additional sources Compilation of sources: http://lrs.ed.uiuc.edu/tseportal/datacollectionmethodologies/jin-tselink/tselink.htm Mgt 540 Research Methods Data Analysis 1 Additional sources Compilation of sources: http://lrs.ed.uiuc.edu/tseportal/datacollectionmethodologies/jin-tselink/tselink.htm http://web.utk.edu/~dap/random/order/start.htm

More information

Some Critical Information about SOME Statistical Tests and Measures of Correlation/Association

Some Critical Information about SOME Statistical Tests and Measures of Correlation/Association Some Critical Information about SOME Statistical Tests and Measures of Correlation/Association This information is adapted from and draws heavily on: Sheskin, David J. 2000. Handbook of Parametric and

More information

Humulin (LY041001) Page 1 of 1

Humulin (LY041001) Page 1 of 1 (LY041001) These clinical study results are supplied for informational purposes only in the interests of scientific disclosure. They are not intended to substitute for the FDA-approved package insert or

More information

Overview. Longitudinal Data Variation and Correlation Different Approaches. Linear Mixed Models Generalized Linear Mixed Models

Overview. Longitudinal Data Variation and Correlation Different Approaches. Linear Mixed Models Generalized Linear Mixed Models Overview 1 Introduction Longitudinal Data Variation and Correlation Different Approaches 2 Mixed Models Linear Mixed Models Generalized Linear Mixed Models 3 Marginal Models Linear Models Generalized Linear

More information

Two-Sample T-Tests Allowing Unequal Variance (Enter Difference)

Two-Sample T-Tests Allowing Unequal Variance (Enter Difference) Chapter 45 Two-Sample T-Tests Allowing Unequal Variance (Enter Difference) Introduction This procedure provides sample size and power calculations for one- or two-sided two-sample t-tests when no assumption

More information

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POINTS TO CONSIDER ON MULTIPLICITY ISSUES IN CLINICAL TRIALS

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POINTS TO CONSIDER ON MULTIPLICITY ISSUES IN CLINICAL TRIALS The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 19 September 2002 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POINTS TO CONSIDER ON MULTIPLICITY

More information

Multiple logistic regression analysis of cigarette use among high school students

Multiple logistic regression analysis of cigarette use among high school students Multiple logistic regression analysis of cigarette use among high school students ABSTRACT Joseph Adwere-Boamah Alliant International University A binary logistic regression analysis was performed to predict

More information

Study Guide for the Final Exam

Study Guide for the Final Exam Study Guide for the Final Exam When studying, remember that the computational portion of the exam will only involve new material (covered after the second midterm), that material from Exam 1 will make

More information

Time series analysis as a framework for the characterization of waterborne disease outbreaks

Time series analysis as a framework for the characterization of waterborne disease outbreaks Interdisciplinary Perspectives on Drinking Water Risk Assessment and Management (Proceedings of the Santiago (Chile) Symposium, September 1998). IAHS Publ. no. 260, 2000. 127 Time series analysis as a

More information

200627 - AC - Clinical Trials

200627 - AC - Clinical Trials Coordinating unit: Teaching unit: Academic year: Degree: ECTS credits: 2014 200 - FME - School of Mathematics and Statistics 715 - EIO - Department of Statistics and Operations Research MASTER'S DEGREE

More information

Interpreting Market Responses to Economic Data

Interpreting Market Responses to Economic Data Interpreting Market Responses to Economic Data Patrick D Arcy and Emily Poole* This article discusses how bond, equity and foreign exchange markets have responded to the surprise component of Australian

More information

Supplementary webappendix

Supplementary webappendix Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Giovannoni G, Gold R, Selmaj K, et al,

More information

Permutation Tests for Comparing Two Populations

Permutation Tests for Comparing Two Populations Permutation Tests for Comparing Two Populations Ferry Butar Butar, Ph.D. Jae-Wan Park Abstract Permutation tests for comparing two populations could be widely used in practice because of flexibility of

More information